Healthy Ages 18 and older - Earn up to $3,000
If you've previously submitted an application, call 417-831-2048 to enroll. Or submit your application now.
Participant Requirements: Men and Women, ages 18 and older, Non-smoking. Females must be using an acceptable method of birth control from screening and through completion of the study participation such as complete abstinence and vasectomized partner or oral, transdermal, vaginal, injection, IUD/IUS used in addition with a male condom or be postmenopausal for at least 1 year prior to screening, be surgically sterile via bilateral tubal ligation, bilateral oophorectomy, hysterectomy or bilateral salpingectomy. BMI (Body Mass Index) must be between 33 or less.
What: This clinical research trial is testing the safety and response of an investigational medication being developed for the prevention of COVID-19. This medication will be delivered via intramuscular injection in the upper arm.
When: This study will consist of a 10 day stay and 6 outpatient visits. . Dates are TBD.
How Much: $3,000
Physical: TBD. Please call to be placed on a waiting list.
All study dates are tentative and subject to change.
We will update the study list every Wednesday. Be sure to check with us either by calling or by looking online. Call (417) 831-2048 or come by 1820 West Mt. Vernon for more information. Office hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
At QPS, the health and safety of our participants, employees, families and communities is of the utmost importance during this time and will be enrolling studies as soon as possible!
Due to the COVID-19 Pandemic, you are now able to sign up for this particular study by clicking the "Sign-Up Button" below and a QPS Recruiting Coordinator will contact you directly.
If you haven’t already, please fill out an application and a QPS Recruiting Coordinator will contact you
Don't forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.**No referral bonuses are paid out for outpatient vaccine studies.